GSK plc - Laporan Laba Rugi (TTM)

GSK plc
US ˙ OTCPK ˙ GB00BN7SWP63

Laporan Laba Rugi (TTM)

Laporan Laba Rugi GSK plc menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 34,259 24,354 30,164 28,378 26,359 24,696 26,731 27,822 29,024 29,324 29,085 29,334 29,652 30,328 30,740 31,446 31,311 31,376 31,529 31,631
Change (%) -28.91 23.86 -5.92 -7.11 -6.31 8.24 4.08 4.32 1.03 -0.82 0.86 1.08 2.28 1.36 2.30 -0.43 0.21 0.49 0.32
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 10,939 7,321 9,736 8,990 8,234 8,033 9,096 9,558 9,481 9,407 8,620 8,379 8,737 8,388 8,400 8,553 8,638 8,845 8,854 8,956
Change (%) -33.07 32.99 -7.66 -8.41 -2.44 13.23 5.08 -0.81 -0.78 -8.37 -2.80 4.27 -3.99 0.14 1.82 0.99 2.40 0.10 1.15
% of Revenue 31.93 30.06 32.28 31.68 31.24 32.53 34.03 34.35 32.67 32.08 29.64 28.56 29.47 27.66 27.33 27.20 27.59 28.19 28.08 28.31
Gross Operating Profit 23,320 17,033 20,428 19,388 18,125 16,663 17,635 18,264 19,543 19,917 20,465 20,955 20,915 21,940 22,340 22,893 22,673 22,531 22,675 22,675
Change (%) -26.96 19.93 -5.09 -6.51 -8.07 5.83 3.57 7.00 1.91 2.75 2.39 -0.19 4.90 1.82 2.48 -0.96 -0.63 0.64 0.00
% of Revenue 68.07 69.94 67.72 68.32 68.76 67.47 65.97 65.65 67.33 67.92 70.36 71.44 70.53 72.34 72.67 72.80 72.41 71.81 71.92 71.69
SG&A 10,719 7,041 9,176 8,285 7,436 6,784 7,104 7,429 7,803 8,179 8,460 8,767 8,965 9,156 9,070 9,027 10,582 10,853 10,934 10,804
Change (%) -34.31 30.32 -9.71 -10.25 -8.77 4.72 4.57 5.03 4.82 3.44 3.63 2.26 2.13 -0.94 -0.47 17.23 2.56 0.75 -1.19
% of Revenue 31.29 28.91 30.42 29.20 28.21 27.47 26.58 26.70 26.88 27.89 29.09 29.89 30.23 30.19 29.51 28.71 33.80 34.59 34.68 34.16
R&D 4,537 4,397 4,622 4,566 4,640 4,627 4,691 4,741 4,905 5,153 5,282 5,436 5,580 5,823 5,956 6,049 6,042 6,078 6,103 6,218
Change (%) -3.09 5.12 -1.21 1.62 -0.28 1.38 1.07 3.46 5.06 2.50 2.92 2.65 4.35 2.28 1.56 -0.12 0.60 0.41 1.88
% of Revenue 13.24 18.05 15.32 16.09 17.60 18.74 17.55 17.04 16.90 17.57 18.16 18.53 18.82 19.20 19.38 19.24 19.30 19.37 19.36 19.66
OpEx 25,631 18,304 22,952 21,246 19,802 19,062 20,435 21,410 21,535 22,002 21,659 21,492 22,055 21,925 22,013 22,413 24,376 25,192 25,278 25,263
Change (%) -28.59 25.39 -7.43 -6.80 -3.74 7.20 4.77 0.58 2.17 -1.56 -0.77 2.62 -0.59 0.40 1.82 8.76 3.35 0.34 -0.06
% of Revenue 74.82 75.16 76.09 74.87 75.12 77.19 76.45 76.95 74.20 75.03 74.47 73.27 74.38 72.29 71.61 71.27 77.85 80.29 80.17 79.87
Operating Income 8,628 6,050 7,212 7,132 6,557 5,634 6,296 6,412 7,489 7,322 7,426 7,842 7,597 8,403 8,727 9,033 6,935 6,184 6,251 6,368
Change (%) -29.88 19.21 -1.11 -8.06 -14.08 11.75 1.84 16.80 -2.23 1.42 5.60 -3.12 10.61 3.86 3.51 -23.23 -10.83 1.08 1.87
% of Revenue 25.18 24.84 23.91 25.13 24.88 22.81 23.55 23.05 25.80 24.97 25.53 26.73 25.62 27.71 28.39 28.73 22.15 19.71 19.83 20.13
Interest Expense -827 -844 -830 -791 -790 -762 -769 -783 -788 -819 -813 -798 -782 -710 -675 -663 -636 -615 -606 -621
Change (%) 2.06 -1.66 -4.70 -0.13 -3.54 0.92 1.82 0.64 3.93 -0.73 -1.85 -2.01 -9.21 -4.93 -1.78 -4.07 -3.30 -1.46 2.48
% of Revenue -2.41 -3.47 -2.75 -2.79 -3.00 -3.09 -2.88 -2.81 -2.71 -2.79 -2.80 -2.72 -2.64 -2.34 -2.20 -2.11 -2.03 -1.96 -1.92 -1.96
Net Income 6,371 5,749 5,257 4,389 4,313 4,385 5,114 4,557 14,210 14,956 14,644 15,430 6,073 4,928 4,484 4,033 2,511 2,575 3,153 3,423
Change (%) -9.76 -8.56 -16.51 -1.73 1.67 16.62 -10.89 211.83 5.25 -2.09 5.37 -60.64 -18.85 -9.01 -10.06 -37.74 2.55 22.45 8.56
% of Revenue 18.60 23.61 17.43 15.47 16.36 17.76 19.13 16.38 48.96 51.00 50.35 52.60 20.48 16.25 14.59 12.83 8.02 8.21 10.00 10.82

Source: Capital IQ

Other Listings
DE:GS71 € 16.95
MX:GSK1 N
GB:GSKL
GB:GSK £ 1,476.00
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista